Opendata, web and dolomites

STARS SIGNED

Strengthening training of academia in regulatory sciences and supporting regulatory scientific advice (STARS)

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

Project "STARS" data sheet

The following table provides information about the project.

Coordinator
BUNDESINSTITUT FUR ARZNEIMITTEL UND MEDIZINPRODUKTE 

Organization address
address: KURT GEORG KIESINGER ALLEE 3
city: BONN
postcode: 53175
website: www.bfarm.de

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Germany [DE]
 Total cost 1˙986˙000 €
 EC max contribution 1˙986˙000 € (100%)
 Programme 1. H2020-EU.3.1.6. (Health care provision and integrated care)
 Code Call H2020-SC1-2018-Single-Stage-RTD
 Funding Scheme CSA
 Starting year 2019
 Duration (year-month-day) from 2019-01-01   to  2021-12-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    BUNDESINSTITUT FUR ARZNEIMITTEL UND MEDIZINPRODUKTE DE (BONN) coordinator 190˙000.00
2    DEUTSCHES ZENTRUM FUER LUFT - UND RAUMFAHRT EV DE (KOELN) participant 680˙000.00
3    BUNDESINSTITUT FUR IMPFSTOFFE UND BIOMEDIZINISCHE ARZNEIMITTEL DE (LANGEN) participant 190˙000.00
4    AGENTSCHAP COLLEGE TER BEOORDELING VAN GENEESMIDDELEN NL (UTRECHT) participant 120˙000.00
5    LAAKEALAN TURVALLISUUS-JA KEHITTAMISKESKUS FI (KUOPIO) participant 112˙500.00
6    LAKEMEDELSVERKET SE (UPPSALA) participant 86˙250.00
7    THE MEDICINES AUTHORITY MT (SAN GWANN) participant 82˙500.00
8    AGENCIA ESPANOLA DE MEDICAMENTOS Y PRODUCTOS SANITARIOS ES (MADRID) participant 75˙000.00
9    AGENZIA ITALIANA DEL FARMACO IT (ROMA) participant 57˙000.00
10    URZAD REJESTRACJI PRODUKTOW LECZNICZYCH, WYROBOW MEDYCZNYCH I PRODUKTOW BIOBOJCZYCH PL (WARSAW) participant 53˙250.00
11    ORSZAGOS GYOGYSZERESZETI ES ELELMEZES-EGESZSEGUGYI INTEZET HU (BUDAPEST) participant 52˙500.00
12    VALSTYBINE VAISTU KONTROLES TARNYBAPRIE LIETUVOS RESPUBLIKOS SVEIKATOS APSAUGOS MINISTERIJOS LT (VILNIUS) participant 42˙500.00
13    MEDICINES AND HEALTHCARE PRODUCTS REGULATORY AGENCY UK (LONDON) participant 40˙875.00
14    HEALTH PRODUCTS REGULATORY AUTHORITY IE (DUBLIN) participant 37˙500.00
15    FEDERAL AGENCY FOR MEDICINES AND HEALTH PRODUCTS BE (BRUSSELS) participant 35˙625.00
16    OSTERREICHISCHE AGENTUR FUR GESUNDHEIT UND ERNAHRUNGSSICHERHEIT GMBH AT (WIEN) participant 33˙750.00
17    AGENCE NATIONALE DE SECURITE DU MEDICAMENT ET DES PRODUITS DE SANTE FR (SAINT DENIS CEDEX) participant 30˙000.00
18    INFARMED - AUTORIDADE NACIONAL DO MEDICAMENTO E PRODUTOS DA SAUDE IP PT (LISBOA) participant 22˙500.00
19    STATNI USTAV PRO KONTROLU LECIV CZ (PRAHA) participant 22˙125.00
20    ZALU VALSTS AGENTURA LV (RIGA) participant 14˙625.00
21    THE EUROPEAN MEDICINES AGENCY NL (AMSTERDAM) participant 7˙500.00

Map

 Project objective

Lack of specific relevant know-how in regulatory science delays the development of new treatment strategies or limits the chances that promising innovations will reach patients. STARS aims to improve the direct regulatory impact of results obtained in medical research. Seventeen European countries are represented in the consortium through their national competent authorities, alongside academic and industry representatives, and associations with relevant experience. The work plan includes the development of a Comprehensive Inventory of existing support activities based on a detailed analysis of the currently established programmes. This analysis is also the basis for development of a Common Strategy to strengthen regulatory sciences and two curricula, the Core Curriculum specifying essential knowledge for the professional training of clinical scientists and the Comprehensive Curriculum defining relevant knowledge for specific post-graduate programmes. Three pilot projects aim (i) to transfer an identified best practice example for training programmes to other EEA countries, (ii) to implement a new support activity addressing a gap in regulatory knowledge of significant relevance and (iii) to implement the Comprehensive Curriculum. STARS will deliver consensual recommendations ensuring sustainable support of academic research and will propose additional support mechanisms based on a comprehensive analysis of needs. STARS has the objective and the potential to complement, coordinate and harmonise regulatory efforts among Member States and at European level to support academic health research for the benefit of patients. The aim is to reach academic researchers very early in the planning of relevant grant applications. A further aim is to strengthen regulatory knowledge in general by reaching clinical scientists during professional training and qualification.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "STARS" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "STARS" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.1.6.)

PERMIT (2020)

PERsonalised MedicIne Trials

Read More  

EBRA (2018)

European Brain Research Area

Read More  

SINO-EU-PerMed (2020)

Widening Sino‐EU policy and research cooperation in Personalised Medicine

Read More